0.00Open0.00Pre Close0 Volume0 Open Interest10.00Strike Price0.00Turnover190.98%IV-28.77%PremiumSep 20, 2024Expiry Date4.04Intrinsic Value100Multiplier27DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type0.8212Delta0.0358Gamma2.81Leverage Ratio-0.0364Theta0.0048Rho2.31Eff Leverage0.0100Vega
R1 RCM Stock Discussion
$Futu Holdings Ltd (FUTU.US)$ $MasterCard (MA.US)$ $Visa (V.US)$ $Palantir (PLTR.US)$ $Alibaba (BABA.US)$ $Medical Properties Trust Inc (MPW.US)$ $Realty Income (O.US)$ $Wynn Resorts (WYNN.US)$ $Coinbase (COIN.US)$
• $Vertical Aerospace (EVTL.US)$ +46.2% (FLYINGGROUP, one of Europe’s leading business jet operators, has conditionally pre-ordered up to 50 VX4 aircraft)
• $Pinterest (PINS.US)$ +15% (activist Elliott Mgmt has built a 9+% stake, according to WSJ)
• $Citigroup (C.US)$ +4.6% (Citigroup Q2 EPS $2.19 Beats $1.69 Estimate, Sales $19.60B Beat $18.12B Estimate)
• $Red Robin (RRGB.US)$ +3.2% (names new CEO)
• $NexGen Energy (NXE.US)$ +2...
• $Kezar Life Sciences (KZR.US)$ +92% (announces positive top line results from the MISSION Phase 2 trial)
• $Sutro Biopharma (STRO.US)$ +24.5% (Sutro Biopharma and Astellas to collaborate to advance novel immunostimulatory antibody-drug conjugates)
• $Ceragon (CRNT.US)$ +17.7% (AVNW to acquire all shares of CRNT that it does not already own for $2.80/sh)
• $Trip.com (TCOM.US)$ +15.6% (In reaction to earnings/guidance)
• $Apyx Medical (APYX.US)$ +8% (anno...
R1 leads technological innovation among outsourcing revenue cycle management providers. In RCM automation, I think it's at least a year ahead of its peers. Automation itself is not unique to R1, but when applied to R1's unique end-to-end and integrated platform, I believe it will continue to strengthen the company's competitive advantage and help create more value for existing customers over a longer period of time.
Basically, there are two main reasons for RCM's inefficiency :(1) too many single point solutions that are not integrated effectively; (2) Organizational island effect leads to duplication of work and poor execution. In addition, the low-skill nature of many tasks also leads to high staff turnover, making it difficult to improve operations across the board. R1's fully outsourced integration platform addresses both of these issues and can be accelerated and enhanced by leveraging artificial intelligence and automation.
R1 RCM is one of the things I see as long-term investment value as I see strengthening macro trends driving an increase in the number of RCM outsourcing decisions over the next few years and R1 is poised to win more and more decisions with the help of these decisions. R1 has been making technology investments and digital transformations that differentiate it from its peers.
No comment yet